Chen Guoqian, Ward Mary F, Sama Andrew E, Wang Haichao
Department of Emergency Medicine, North Shore University Hospital-New York University School of Medicine, Manhasset, NY 11030, USA.
J Interferon Cytokine Res. 2004 Jun;24(6):329-33. doi: 10.1089/107999004323142187.
High mobility group box-1 protein (HMGB1, formerly known as HMG-1), a highly conserved ubiquitous protein, has been for a long time described as a nuclear DNA-binding protein involved in nucleosome stabilization and gene transcription. Recent discoveries indicate that HMGB1 is released from activated innate immune cells or necrotic cells and functions as an important mediator of endotoxemia, sepsis, arthritis, and local inflammation. Therapeutic agents that inhibit HMGB1 release or action confer significant protection against endotoxemia, sepsis, and arthritis in animal models and thus hold potential for the clinical management of various inflammatory diseases.
高迁移率族蛋白B1(HMGB1,以前称为HMG-1)是一种高度保守的普遍存在的蛋白质,长期以来被描述为一种参与核小体稳定和基因转录的核DNA结合蛋白。最近的发现表明,HMGB1从活化的先天免疫细胞或坏死细胞中释放出来,并作为内毒素血症、脓毒症、关节炎和局部炎症的重要介质发挥作用。在动物模型中,抑制HMGB1释放或作用的治疗药物可对内毒素血症、脓毒症和关节炎提供显著保护,因此在各种炎症性疾病的临床管理中具有潜力。